Description

Versed® (Midazolam) Oral Syrup 2 mg/mL

Product Description

Versed® (midazolam) oral syrup 2 mg/mL is a short-acting benzodiazepine medication formulated as a clear, cherry-flavored liquid for oral administration. It is primarily used in hospital and clinical settings under strict medical supervision.Buy versed ( Syrup ) 2 mg/mL

Key Features & Benefits

✔ Fast-Acting Sedation – Onset within 15–30 minutes.Buy versed ( Syrup ) 2 mg/mL 
✔ Precise Dosing – 2 mg per 1 mL for accurate administration
✔ Pediatric & Geriatric Use – Preferred for patients who cannot swallow pills
✔ Procedural Sedation – Used before surgeries, dental work, or diagnostic tests
✔ Anxiolytic & Amnesic Effects – Reduces anxiety and memory of stressful procedures

Indications

✅ Preoperative sedation (adults & children)
✅ Anxiety relief before medical procedures
✅ Short-term treatment of severe insomnia (hospital use only)
✅ Sedation for mechanically ventilated patients (ICU settings)

Dosage & Administration

• Adults:

  • Pre-procedural sedation: 0.25–0.5 mg/kg (max 20 mg)

  • Insomnia (hospital use): 5–15 mg at bedtime

• Pediatrics:

  • Dose varies by weight (0.25–1 mg/kg, max 10 mg)

• Administration:

  • Measure with oral syringe for accuracy

  • Best taken on an empty stomach (food delays absorption)

Safety & Warnings

⚠ Controlled Substance (Schedule IV) – High potential for dependence & abuse
⚠ Respiratory Depression Risk – Fatal if combined with opioids/alcohol
⚠ Must Be Supervised by a Doctor – Not for home or long-term use
⚠ Pregnancy Warning (Category D) – May cause fetal harm

Side Effects

🔹 Common: Drowsiness, dizziness, headache, nausea
🔹 Serious (Rare):

• Severe breathing problems

• Paradoxical agitation (in children)

• Memory loss (anterograde amnesia)

Storage & Handling

• Store at 20–25°C (68–77°F)

• Keep tightly closed – Protect from light

• Use within 90 days after opening

Prescription Required – Not available OTC

For medical use only. Never self-administer.

Pregnancy

Pregnancy Exposure Registry

There is a pregnancy registry that monitors pregnancy outcomes in women exposed to psychiatric medications, including midazolam HCl syrup, during pregnancy. Healthcare providers are encouraged to register patients by calling the National Pregnancy Registry for Psychiatric Medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/pregnancyregistry/.

Risk Summary

Neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal [see WARNINGS: Neonatal Sedation and Withdrawal Syndromeand PRECAUTIONS: Clinical Considerations]. Available data from published observational studies of pregnant women exposed to benzodiazepines do not report a clear association with benzodiazepines and major birth defects (see Data).

The background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated risk of major birth defects and of miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively.

Clinical Considerations